BeStock  

Pulse Biosciences PLSE

US equityMarket cap rank #2349Medical Instruments & Supplies
$45.55 +$1.14 (+2.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $45.50 -0.11%
Open$44.00
Prev close$44.41
Day range$43.72 – $46.06
Volume466.9K
Market cap$3.35B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership16.5%+0.32 pts vs. prior quarter
Institutions holding157+21 vs. prior quarter
Insider trades (recent)38 buys / 12 sellsNet buying
Short interest4.07% of floatDays to cover 8.3 · as of 30 Oct 2026
Short-sale volume share24.8%5-day average of daily volume

Short-sale volume as % of daily volume

14%20%26%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$608.8K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$1.6MSuper−$1.0MBig−$690.8KMid−$108.9KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 73.1% of shares outstanding.

Largest holders

  • Robert Duggan66.38%
  • BlackRock2.28%
  • Bank of America Corporation1.97%
  • Vanguard Capital Management, LLC1.28%
  • Mahkam Zanganeh1.19%
  • Portolan Capital Management, LLC1.02%
  • T. Rowe Price Group, Inc.1.02%
  • Balyasny Asset Management L.P.0.98%

By investor type

  • Individual/Insider68.04%
  • Mutual Fund9.55%
  • Hedge Fund3.48%
  • Public Company2.23%
  • Private Company0.96%
  • Sovereign Wealth Fund0.14%
  • Insurance Company0.10%
  • Government Pension Fund0.06%

Reported short interest has risen from 3.88% to 4.07% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +503,373 0.7%
BlackRock Mutual Fund 2026/Q3 +207,194 2.3%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +160,965 0.2%
TD Asset Management Mutual Fund 2026/Q3 +154,066 0.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +149,310 1.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +61,042 0.3%
Jane Street Group, LLC Private Company 2026/Q3 +39,342 0.1%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +29,378 0.0%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +31,990 0.0%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +46,627 0.1%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +733,779 1.0%
Bank of America Corporation Public Company 2026/Q3 +580,550 2.0%
Citadel Advisors LLC Hedge Fund 2026/Q3 +484,364 0.9%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +452,939 1.0%
UBS Asset Management Mutual Fund 2026/Q3 +240,712 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
31 Aug 2026 Liane Teplitsky Chief Operating Officer Open Market Acquisition +2,025 $49.95 4,095
27 Aug 2026 Liane Teplitsky Chief Operating Officer Open Market Acquisition +2,070 $48.35 2,070
7 Aug 2026 Liane Teplitsky Chief Operating Officer Other Derivative Acquisition +200,000 – 200,000
7 Aug 2026 Liane Teplitsky Chief Operating Officer Other Derivative Acquisition +700,000 $19.06 700,000
10 Jun 2026 Richard van den Broek Independent Director Other Derivative Acquisition +38,423 $26.89 8,423
10 Jun 2026 Robert Duggan Independent Co-Chairman Other Derivative Acquisition +42,495 $26.89 12,495
10 Jun 2026 Maria Degois-Sainz Independent Director Other Derivative Acquisition +33,793 $26.89 3,793
10 Jun 2026 Mahkam Zanganeh Independent Director Other Derivative Acquisition +44,504 $26.89 14,504
10 Jun 2026 Manmeet Soni Lead Independent Director Other Derivative Acquisition +30,000 $26.89 30,000
10 May 2026 Paul LaViolette President, CEO & Co-Chairman of the Board Open Market Acquisition +15,000 $19.69 15,846
10 May 2026 Robert Duggan Independent Co-Chairman Open Market Acquisition +660,233 $19.69 48,820,236
22 Mar 2026 Darrin Uecker CTO & Director Other Derivative Acquisition +100,000 – 100,000
17 Feb 2026 Kevin Danahy Former Chief Commercial Officer Derivative Exercise and Sale -5,000 $23.64 43,298
16 Feb 2026 Kevin Danahy Former Chief Commercial Officer Derivative Exercise and Sale -60,000 $23.63 43,298
11 Feb 2026 Kevin Danahy Former Chief Commercial Officer Intent to Sell (Form 144) -50,000 $25.25 –
10 Feb 2026 Kevin Danahy Former Chief Commercial Officer Derivative Exercise and Sale -60,000 $25.20 43,298
8 Feb 2026 Kevin Danahy Former Chief Commercial Officer Intent to Sell (Form 144) -75,000 $20.75 –
4 Feb 2026 Maria Degois-Sainz Independent Director Other Derivative Acquisition +53,104 $14.72 3,104
1 Oct 2025 Kevin Danahy Former Chief Commercial Officer Derivative Exercise and Sale -4,600 $18.53 43,298
18 Sep 2025 Kevin Danahy Former Chief Commercial Officer Derivative Exercise and Sale -20,400 $18.49 43,298

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,900,286 4.1% 8.3
15 Oct 2026 3,004,624 4.2% 7.2
30 Sep 2026 3,312,487 4.6% 5.6
15 Sep 2026 3,139,674 4.4% 3.9
31 Aug 2026 3,121,131 4.4% 7.9
14 Aug 2026 2,765,732 3.9% 6.4

Discussion

No comments yet — be the first to weigh in on PLSE.

Sign in to join the discussion.

Scroll to Top